Renal Failure Presentation
Renal Failure Presentation
Renal Failure Presentation
FAILURE
The Nurses
McTall & McShorty
The Radical Renal Team
The Nurses
McSmall & McGiant
Case Study
Tia Smith is a 26 year old female patient who is 10 hours post-
partum following an emergency C-section for twins. She was 33.5
weeks pregnant and had a difficult pregnancy with PIH (pregnancy
induced hypertension) and frequent urinary tract infections. On
admission Tia was diagnosed with HELLP syndrome (hemolysis,
elevated liver enzymes, low platelets) which necessitated immediate
delivery of her babies. During the C-section Tia became
hypovolemic resulting from massive hemorrhaging and required
blood products and fluid replacements. Tia eventually developed
hypovolemic shock and remained unstable for 2 hours. For the past
nursing shift Tia has been hypotensive with blood pressures ranging
from 59/47 to 95/52. Tia’s urinary output has been 2-12cc/hr of
brown cloudy foul smelling urine. During your morning assessment
you discover the following:
Case cont’d
• VS: T: 37.4 P: 125bpm R: 33 BP: 96/62
• Respiratory: Chest is clear fine crackles heard throughout all lung fields,
there is diminished A/E at the bottom of the R & L lobes
• CV: S1, S2 audible with pericardial friction, bounding rapid pulse
• Mental Status: drowsy and with assistance will orient slowly to PPT, pt c/o
persistent hiccups
• Neurovascular: edema, skin cool & pale, bruises observed throughout
extremities, skin turgor poor, bilateral decreased sensation in feet
• GI: pt c/o N&V
• Genitourinary: pt has foley catheter draining brown cloudy foul smelling
urine at 2-12cc/hr
• Psychosocial: pt very emotional and crying at times because she cannot be
with her newborn babies and is unable to breastfeed, she is concerned for
their health, and does not understand how this happened to her
So… What is Tia’s diagnosis?
http://www.venofer.com/VenoferHCP/Venofer_kidneyFunction.html
Nephron
http://www.venofer.com/VenoferHCP/Venofer_kidneyFunction.html
10 Functions of the Kidney’s
• Urine Formation: Formed in the nephrons through a
complex three-step process: GF, tubular reabsorption, and
tubular secretion
• Excretion of waste products: eliminates the body’s
metabolic waste products (urea, creatinine, phosphates,
sulfates)
• Regulation of electrolytes: volume of electrolytes
excreted per day is exactly equal to the volume ingested
– Na – allows the kidney to regulate the volume of body fluids,
dependent on aldosterone (fosters renal reabsorption of Na)
– K – kidneys are responsible for excreting more than 90% of total
daily intake
• RETENTION OF K IS THE MOST LIFE-THREATENING
EFFECT OF RENAL FAILURE
Renin-Angiotensin System
http://en.wikipedia.org/wiki/Image:Renin-angiotensin-aldosterone_system.png
Kidney Function con’td
• Regulation of acid-base balance: elimination
of sulphuric and phosphoric acid
Kidney function cont’d
• Control of water balance: Normal ingestion of water
daily is 1-2L and normally all but 400-500mL is excreted
in the urine
– Osmolality: degree of dilution or concentration of urine
(#particles dissolved/kg urine (glucose & proteins are osmotically
active agents)
– Specific Gravity: measurement of the kidney’s ability to
concentrate urine (weight of particles to the weight of distilled
water)
– ADH: vasopressin – regulates water excretion and urine
concentration in the tubule by varying the amount of water
reabsorbed.
Still talking about kidney
function…
• Control of blood pressure: BP monitored by the vasa
recta.
– Juxtaglomerular cells, afferent arteriole, distal tubule,
efferent arteriole http://www.wisc-online.com/objects/AP2204/AP2204.swf
• Renal clearance: ability to clear solutes from plasma
– Dependent on… rate of filtration across the
glomerulus, amount reabsorbed in the tubules,
amount secreted into the tubules
– CREATININE
• Regulation of red blood cell production:
Erythropoeitin is released in response to decreased
oxygen tension in renal blood flow. This stimulates the
productions of RBCs (increases amount of hemoglobin
available to carry oxygen)
Kidney function cont’d
• Synthesis of vitamin D to active form: final conversion
of vit D into active form to maintain Ca balance
• Secretion of prostaglandins: important in maintaining
renal blood flow (PGE & PGI). They have a vasodilatory
effect
Timeline of Events
HYPOVOLEMIC HYPOVOLEMIA
SHOCK
LAB VALUES
Medications for ARF
Pharmacologic treatment of ARF has been
attempted on an empirical basis, with varying
success rates. Several promising experimental
therapies in animal models are awaiting human
trials
It is critical to adjust (decrease or discontinue)
medication dosages for patient in acute renal
failure. Administering the average dose to patient
in renal failure can kill a patient.
Medications for ARF continued
Immediate goal is to retain fluid volume deficit through use
of blood products and crystalloids
• Normal Saline (0.9% Na) – only one that is compatible
with blood transfusions
– Restores fluid loss
– Provides electrolytes resembling those of plasma
• Packed RBC
– To increase blood volume
– To restore blood to kidneys
Medications for ARF continued
•Diuretics
–Furosemide (Lasix) only given with severe fluid
overload
•Increases excretion of water by interfering with chloride-binding
cotransport system, which, in turn, inhibits sodium and chloride
reabsorption in the thick ascending loop of Henle and the distal
renal tubule
–Adult dose: 20-80 mg PO/IV once; repeat 6-8h prn or
dose may be increased by 20-40 mg no sooner than 6- 8h
after previous dose until desired effect
–Nursing Assessments: Watch for hypokalemia, assess BP
before and during therapy can cause hypotension
Medications for ARF continued
• Vasodilators
– Dopamine
• In small doses causes selective dilatation of the renal
vasculature, enhancing renal perfusion.
• Reduces sodium absorption, thereby decreasing the energy
requirement of the tubules. This enhances urine flow, which,
in turn, helps prevent tubular cast obstruction.
– Adult dose: 2-5 mcg/kg/min
– Nursing Assessments: Monitor BP during
administration, stop infusion if BP drops 30mm Hg,
Monitor I&O
Medications for ARF continued
• Alkalinizer
– Sodium Bicarbonate
– Increases plasma bicarbonate, which buffers Hydrogen ion
concentration; reverses acidosis
– Adult Dose: Initial dose IV bolus 1 mEq/kg, then infuse 2-5
mEq/kg over 4-8 hr depending on CO2, pH
• Dilute with equal amounts of NS, 2-5 mEq/kg
– Nursing assessments: Assess resp. and pulse rate,
rhythm, depth, lung sounds, monitor I&O,
electrolytes, blood pH, PO2, HCO3, monitor urine pH,
and UO during beginning of treatment, monitor for
alkalosis, monitor ABGs and blood studies
13 have passed and now Tia is
diagnosed with…
Chronic Renal Failure
• 13 years have passed Tia is now 39 years of age and
has been experiencing declining renal function over the
past 13 years. Tia has lost 15lbs on her already small
frame, she feels generally ill most of the time with
frequent N&V, she suffers from fatigue, muscle twitching
& cramps decreased sensation in her hands and feet and
generalized puritus. The Physician has diagnosed Tia
with ESRD and has determined that long term dialysis
will be required.
Chronic Renal Failure
ESRF
Definition
• Also known as End-Stage Renal Failure (ESRF),
is a progressive deterioration in renal function in
which the body’s ability to maintain metabolic
and fluid and electrolyte balance fails, resulting
in uremia (retention of urea and other
nitrogenous wastes in the blood).
• decreased kidney glomerular filtration rate (GFR)
of <60 mL/min/1.73 m2 for 3 or more months
Statistics
• In the U.S. The US Renal Data System (USRDS) has
shown a dramatic increase in patients with CRF who
require chronic dialysis or transplantation. In 1999, there
were 340,000 such patients, but, by 2010, this number is
projected to reach 651,000.
• Internationally: The incidence rates of end-stage
renal disease (ESRD) have increased steadily
internationally since 1989. The United States has the
highest incident rate of ESRD, followed by Japan. Japan
has the highest prevalence per million population, with
the United States taking second place.
Statistics Cont’d
• Mortality /Morbidity: CRF is a major cause of
morbidity and mortality, particularly at the later stages.
The 5-year survival rate for a patient undergoing chronic
dialysis is approximately 35%. This is approximately
25% in patients with diabetes. The most common cause
of death in the dialysis population is cardiovascular
disease.
• Race: Affects all races
Pathophysiology
Glomerulonephritis is the
inflammation and damage of the
filtration system of the kidney and
can cause kidney failure.
Postinfectious conditions and
Lupus are among the many causes
of glomerulonephritis.
More Causes
Polycystic Kidney Disease is an example of a hereditary cause
of chronic kidney disease wherein both kidneys have multiple
cysts
LAB VALUES
Medications for CRF
• Diuretics
– Furosemide (Lasix) only given with severe fluid
overload
• Increases excretion of water by interfering with chloride-
binding cotransport system, which, in turn, inhibits sodium
and chloride reabsorption in the thick ascending loop of Henle
and the distal renal tubule
– Adult dose: 20-80 mg PO/IV once; repeat 6-8h
prn or dose may be increased by 20-40 mg no
sooner than 6-8h after previous dose until
desired effect
– Nursing Assessments: Watch for hypokalemia,
assess BP before and during therapy can cause
hypotension
Medications for CRF continued
• Phosphate-lowering agents
– Calcium acetate (Calphron, PhosLo)
• Combines with dietary phosphorus to form insoluble calcium
phosphate, which is excreted in feces.
– Adult dose: 1-2 g PO bid-tid with each meal; increase
to bring serum phosphate value to 6 mg/dL as long as
hypercalcemia does not develop;
– Calcium carbonate (Caltrate, Apo-Cal, Tums)
• Successfully normalizes phosphate concentrations
• Neutralizes gastric acidity, increase serum Ca
– Adult dose: 1-2 g PO divided bid-tid; with meals as a
phosphorous binder; between meals as a calcium
supplement
Phosphate-lowering agents
– Calcitriol (Rocaltrol, Calcijex)
• Increases intestinal absorption of calcium for treatment of
hypocalcemia and increases renal tubular resorption of
phosphate
– Adult dose for hypocalcemia during chronic dialysis:
• 0.25 mcg/day or every other day, may require 0.5-1 mcg/day
PO
– Sevelamer (Renagel)
• Indicated for the reduction of serum phosphorous in patients
with ESRD.
– Adult dose: Initial: 800-1600 mg PO tid with meals
Maintenance: Increase or decrease by 400-800 mg per
meal q2wk to maintain serum phosphorous at 6 mg/dL
or less
Phosphate-lowering agents
• Lanthanum carbonate
(Fosrenal)
– for reduction of high
phosphorus levels in
patients with ESRD
– Adult dose: Initial:
250-500 mg PO tid pc
(chewable tabs); adjust
dose q2-3wk to target
serum phosphorus
level
Maintenance: 500-
1000 mg PO tid pc
Phosphate-lowering agents
– Doxercalciferol (Hectorol)
• To lower parathyroid hormone levels in patients undergoing
chronic kidney dialysis. Increases serum Ca
– Adult dose: 10 mcg PO 3 times/wk at dialysis;
increase dose by 2.5 mcg/8 wk if iPTH is not lowered
by 50% and fails to reach the target range; not to
exceed 20 mcg/3 times/wk
Alternatively, 4 mcg IV 3 times/wk; may adjust dose
by 1-2 mcg/8 wk to maintain iPTH levels
– Nursing Assessment for all phosphate lowering
agents: Monitor BUN, creatinine, chloride,
electrolytes, urine pH, urinary calcium, mg,
phosphate, urinalysis urinary Ca should be 9-10mg/dl,
assess for hypocalcemia: headache, N/V, confusion
Medications for CRF continued
• Anemia
– Epoetin alfa (Epogen, Procrit)
• Stimulates RBC production
– Adult dose: 50 -150 U/kg IV/SC 3 times per week,
then adjust dose by 25 U/kg/dose to maintain
appropriate Hct; maintenance 12.5-25 U/kg, titrate to
target Hct,
– Nursing Assessment: Monitor renal studies: urinalysis,
protein, blood, BUN, creatinine; I&O. Monitor blood
studies, Hgb, Hct, RBC, WBC, INR, PTT
Medications for CRF continued
– Darbepoetin (Aranesp)
• Stimulates erythropoiesis
– Adult dose: 0.45 ug/kg IV/SC as a single
injection, titrate not to exceed a target Hgb of
12 g/dl
– Has a longer half-life than epoetin alfa
– Nursing Assessments: Assess blood studies,
renal studies; assess BP, check for rising BP as
Hct rises
Medications for CRF continued
• Iron Salts
– To treat anemia
– Ferrous sulfate (Feosol, Feratab, Slow FE)
• Replaces iron stores need for RBC development
– Adult dose: 100-200mg tid
– Iron sucrose (Venofer)
• Used to treat iron deficiency dute to chronic hemodialysis
– Adult dose: IV 5ml (100mg of elemental iron) given
during dialysis, most will need 1000mg of elemental
iron over 10 dialysis
• Nursing Assessments: Monitor blood studies,
Hct, Hgb, total Fe, monthly. Assess bowel
elimination for constipation
Dialysis
What is Dialysis?
• Dialysis is a type of renal replacement therapy which is used to
provide artificial replacement for lost kidney function due to acute or
chronic kidney failure
• It is a life support treatment, it does not cure acute or chronic renal
failure
• May be used for very sick clients who have suddenly lost kidney
function
• May be used for stable clients who have permanently lost kidney
function
• Healthy kidneys remove waste products (potassium, acid, urea) from
the blood and they also remove excess fluid in the form of urine
• Dialysis has to duplicate both of these functions
Dialysis – waste removal
Ultrafiltration – fluid removal
Principle of Dialysis
• Dialysis works on the principle of diffusion of
solutes along a concentration gradient across a
semipermiable membrane
• Blood passes on one side of the semipermeable
membrane, and a dialysis fluid is passed on the
other side
• By altering the composition of the dialysis fluid,
the concentrations of the undesired solutes
(potassium, urea) in the fluid are low, but the
desired solutes (sodium) are at their natural
concentration found in healthy blood
Prescription for Dialysis
• A prescription for dialysis is given by a
physician who specializes in the kidney
(nephrologist)
• The MD will set various parameters for the
treatment
Time and duration of the dialysis sessions
Size of the dialyzer
Rate of blood flow
2 Main Types of Dialysis
• Hemodialysis
• Peritoneal Dialysis
Hemodialysis
Adapted from National Institute of Diabetes and Digestive and Kidney Diseases.
National Institute of Diabetes and Digestive and Kidney Diseases. End-stage renal disease: choosing a treatment that's right for
you. Available at: http://www.niddk.nih.gov/health/kidney/pubs/esrd/esrd.htm. Accessed May 10, 2000.
What is Hemodialysis (HD)?
• Client’s blood is passed through a system of tubing
(dialysis circuit) via a machine to a semipermeable
membrane (dialyzer) which has the dialysis fluid running
on the other side
• The cleansed blood is then returned via the circuit back to
the body
• The dialysis process is very efficient (much higher than in
the natural kidneys), which allows treatments to take
place intermittently (usually 3 times a week), but fairly
large volumes of fluid must be removed in a single
treatment which can be very demanding on a client
Side Effects of HD
• The side effects are proportionate to the amount of fluid
being removed
• Decreased blood pressure
• Fatigue
• Chest pains
• Leg cramps
• Headaches
• Electrolyte imbalance
• N&V
• Reaction to the dialyzer
• Air embolism
Complications of HD
• Because HD requires access to the circulatory system,
clients have a portal of entry for microbes, which could
lead to infection
The risk of infection depends on the type of access used
• Bleeding may also occur at the access site
• Blood clotting was a serious problem in the past, but the
incidence of this has decreased with the routine use of
anticoagulants (Heparin is the most common)
Anticoagulants also come with their own risk of side effects and
complications
Rare Complication of HD
• On the rare occasion, a client may have a severe
anaphylactic reaction
Sneezing
Wheezing
SOB
Back pain
Chest pain
Sudden death
• This can be caused by the sterilant in the dialyzer
or the material in the membrane itself
Three Types of Access for HD
• IV catheter
• Arteriovenous (AV) fistula
• Synthetic graft
• The type of access is influenced by factors such
as expected time course of the clients renal
failure and the condition of the clients
vasculature
• Some clients may have multiple accesses, usually
because an AV fistula or a graft is maturing and
an IV catheter is still being used
IV Catheter
(Central Venous Catheter)
• Consists of a plastic catheter with two lumens which is inserted into a
large vein (vena cava via the internal jugular vein) to allow large
flows of blood to be withdrawn from the first lumen
• The blood goes into the dialysis circuit, and is returned to the body
via the second lumen
Non-tunneled
Tunneled
• This type of access is used for clients who need rapid access for
immediate dialysis
Clients who are likely to recover from ARF
Client with end-stage renal failure
Clients waiting for other sites to mature
• This type of access is very popular for clients because it doesn’t
involve needles for each treatment
Complications of an IV Catheter
• Venous Stenosis
This is the abnormal narrowing of the blood
vessel
Because the catheter is a foreign body in the
vessel, it often provokes an inflammatory
reaction in the vein wall
This results in scarring and narrowing of the
vein, often to the point where the vein
occludes
AV Fistula
• This access is recognized as the preferred access method
• To create a fistula a vascular surgeon joins an artery and a
vein together
• Since this bypasses the capillaries, blood flows at a very
high rate through the fistula
This can be felt by placing a finger over a mature fistula (thrill)
• Usually created in the non-dominant hand
• It can be situated on the hand, forearm or the elbow
• It will take approximately 4-6 weeks to mature
• During treatment, 2 needles are inserted, one to draw
blood out of the body and the other to return blood to the
body
Advantages of an AV Fistula
• Decreased infection rate
• Increased blood flow rates, therefore a
more effective dialysis treatment
• Decreased incidence of thrombosis
Complications of an AV Fistula
• If an AV fistula has a very high flow rate and the
vasculature that supplies the rest of the limb is poor, than
a ‘steal syndrome’ can occur
Blood that enters the limb is drawn into the fistula and returned to
the general circulation without entering the capillaries of the limb
This results in cool extremities of the limb, cramping pains and
possible tissue damage
• Long term complications can be the development of a
bulging in the wall of the vein (aneurysm)
The vessel wall is weakened by the repeated insertion of needles
over time
Can be reduced by careful needling technique
AV Graft
• This is much like a fistula, except an
artificial vessel is used to join the artery
and the vein
• Grafts are used when client’s own
vasculature does not permit a fistula
• An AV graft will mature much faster than
an AV fistula, and it could be ready to use
within days after formation
Complications of an AV Graft
• AV grafts are at high risk for narrowing
where the graft is sewn to the vein
As a result clotting or thrombosis may occur
• As a foreign material is being placed in the
body, there is a greater risk of infection
Equipment Needed for HD
• The HD machine performs the function of
pumping the patient's blood and the dialysate
through the dialyzer.
• The newest dialysis machines on the market are
highly computerized and continuously monitor an
array of safety-critical parameters, including
blood and dialysate flow rates, blood pressure,
heart rate, conductivity, pH, etc.
• If any reading is out of normal range, an audible
alarm will sound to alert the patient-care
technician who is monitoring the patient.
Equipment – Water System
• An extensive water purification system is absolutely
critical for HD
• Since dialysis patients are exposed to vast quantities of
water, which is mixed with the acid bath to form the
dialysate, even trace mineral contaminants or bacterial
endotoxins can filter into the patient's blood.
• Because the damaged kidneys are not able to perform
their intended function of removing impurities, ions that
are introduced into the blood stream via water can build
up to hazardous levels, causing numerous symptoms
including death
• For this reason, water used in HD is purified
Equipment – The Dialyzer
• The dialyzer, or artificial kidney, is the piece of equipment that
actually filters the blood
• The blood is run through a bundle of very thin capillary-like
tubes, and the dialysate is pumped in a chamber bathing the fibers
• The process mimics the physiology of the glomerulus and the rest
of the nephron
• Dialyzers come in many different sizes. A larger dialyzer will
usually translate to an increased membrane area, and an increase
in the amount of undesired solutes removed from the patient's
blood.
• The nephrologist will prescribe the dialyzer to be used depending
on the patient
• Dialyzers are not shared between patients in the practice of reuse.
Peritoneal Dialysis
What is Peritoneal Dialysis (PD)?
• Peritoneal dialysis works by using the body's peritoneal
membrane, which is inside the abdomen, as a semi-
permeable membrane.
• A specially formulated dialysis fluid is instilled around
the membrane, using an indwelling catheter, then dialysis
can occur, by diffusion
• Excess fluid can also be removed by osmosis, by altering
the concentration of glucose in the fluid.
• Dialysis fluid is instilled via a peritoneal dialysis catheter,
which is placed in the patient's abdomen, running from
the peritoneum out to the surface, near the navel
• Peritoneal dialysis is typically done in the patient's home
and workplace, but can be done almost anywhere
Advantages of PD
• Can be done at home
• Relatively easy for the client to learn
• Easy to travel with, bags of solution are
easy to take on holiday
• Fluid balance is usually easier when the
client is on PD than if the client is on HD
Disadvantage of PD
• Requires a degree of motivation and
attention to cleanliness while performing
PD
• There are a number of complications
Complications of PD
• Peritoneal dialysis requires access to the peritoneum. As this
access breaks normal skin barriers, and as people with renal
failure generally have a slightly suppressed immune system,
infection is a relatively common problem
• Long term peritoneal dialysis can cause changes in the peritoneal
membrane, causing it to no longer act as a dialysis membrane as
well as it used to.
• This loss of function can manifest as a loss of dialysis adequacy,
or poorer fluid exchange (also known as ultrafiltration failure)
• Fluid may leak into surrounding soft tissue, often the scrotum in
males
• Hernias are another problem that can occur due to the abdominal
fluid load
Nursing Assessments
• Before client is in the unit, look at the nurses notes from
the treatment before
Any problems, will help nurse plan for the upcoming treatment
• Look at the client
Strength
Gait
Whether client needs assistance
Color
Puffiness
Could be caused by excess fluid, too much to drink, more fluid
should be taken off with each treatment, changes in voiding pattern
(are they voiding less than they did last month)
Assessments Con’t
• Shortness of breath
Could indicate fluid around the lungs
Ask about SOB at night (does client have to sleep in a sitting
position?)
• Ask the client how they are feeling
The client is usually the best source of information
Clients are in 3 times a week, dialysis nurses really get to know their
clients
• Evaluate access
Bruising, swollen, tender
Bruit – listen with the stethoscope for a swishing sound of the blood,
listen all the way up the arm
Thrill – felt with the fingers, tells the nurse if the blood is flowing in
the fistula (client’s are told to feel for this at home when a fistula is
first initiated)
Assessments During Treatment
• Ask client how he/she feels
Dizziness, diaphoretic,
• The machines automatically take BP and HR every 30 minutes
Can program the machines to take it at whatever interval is
necessary (every min, 10 min, 15 min)
• Try to recognize a problem before it starts (ex. Hypovolemic
shock)
• Assess access site
Watch trend of BP
It usually gradually decreases throughout the course of the
treatment, but look for sudden or drastic drops
• Assess access site
Bleeding, swelling, tenderness
Nursing Interventions
• If client comes in with shortness of breath, offer
O2 which can be kept on for the full treatment if
necessary
• Comfort
Client’s are sitting in the same chair for up to four
hours
Offer extra pillows, some clients have special back
pillow they leave in the unit
Ensure TV and audio is working properly
Nursing Interventions Con’t
• If the blood pressure is dropping too quickly:
Slow or stop fluid removal for a time period
The machines are constantly being adjusted
throughout the course of the treatment depending on
the BP
If the BP drops suddenly 200-300cc of normal saline
can be given to balance fluid levels
• Usually, more fluid will be taken off at the beginning of
the treatment, this will allow the client to feel better at the
end
• If the client is elderly, fluid removal starts slowly to ease
them into the treatment
Responsibilities of Nursing Staff
Prior to Dialysis
• Ensure client is ready to sit for up to four
hours
Encourage client to use washroom before
arriving to the unit
Try to avoid laxatives if possible before
treatment
• Ensure client has eaten meal prior to
treatment
Responsibilities of Nursing Staff
After Dialysis
• A dialysis nurse will give unit leader or primary nurse a
verbal report of treatment
Any complications during treatment
Check BP standing and sitting
Assess access site
• Encourage client to rest
Avoid treatments or physio for a couple of hours if possible
• Watch fluid intake
Be aware if client is on fluid restriction
• Check thrill and bruit
• Do not take a BP on access arm
• Do not take blood from access arm
Questions?
Thank you for listening.